Skip to content

VITAL SIGNS MONITOR - Advisor Model # Bci 9200

by Bci Intl., Inc.

510(k) K982279

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

40 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK982279 Date25 Sep 1998ClearedStatusActive

Recalls

40 recalls · FDA

    • Terminated Z-1326-2009 FDA Unclassified (pre-2012) initiated 22 Dec 2008 on shared 510(k) K982279

    Recent improvements were made to the Advisor case plastic resulting in the inserts being deeply embedded into the plastic. This affects the ability of the monitor to be adequately secured on the wall mount bracket or roll stand bracket, resulting in the monitor falling off. There have been no adverse events or injuries reported.

    • Terminated Z-1089-2007 FDA Unclassified (pre-2012) initiated 5 Jun 2007 on shared 510(k) K982279

    Turn off unexpectedly/ Not turn on : monitors turned off unexpectedly sounding the critical failure alarm. Advisor Vital Signs monitors that were off, would not turn back on.

  • 21 recalls, same reason

    • Terminated Z-0229-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0239-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0221-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0235-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0223-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0230-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0231-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0225-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0227-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0232-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0228-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0224-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0238-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0234-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0237-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0220-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0233-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0222-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0240-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0236-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279
    • Terminated Z-0226-06 FDA Unclassified (pre-2012) initiated 1 Sep 2005 on shared 510(k) K982279

    Potential Safety related problem associated with the pace detect function on some Advisor monitors that have impedance respiration capabilities in that random pace markers may appear when the pace detect function is turned on and the primary lead is set to Lead II, III or any of the augmented leads, AVL, AVR or AVF on the Advisor monitor.

  • 12 recalls, same reason

    • Terminated Z-0828-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0830-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0824-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0831-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0827-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0835-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0834-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0832-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0826-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0829-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0833-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279
    • Terminated Z-0825-05 FDA Unclassified (pre-2012) initiated 16 Mar 2005 on shared 510(k) K982279

    Altitude testing of the Advisor with Capnography module found the CO2 (End Tidal and Inspired) values are incorrect when the Advisor is configured to display in the relative units of percent (%) at elevations above 4,100 feet (at standard temperature pressure). The % CO values displayed will be lower than the actual CO2 value.

  • 5 recalls, same reason

    • Terminated Z-0533-05 FDA Unclassified (pre-2012) initiated 5 Jan 2005 on shared 510(k) K982279
    • Terminated Z-0534-05 FDA Unclassified (pre-2012) initiated 5 Jan 2005 on shared 510(k) K982279
    • Terminated Z-0531-05 FDA Unclassified (pre-2012) initiated 5 Jan 2005 on shared 510(k) K982279
    • Terminated Z-0535-05 FDA Unclassified (pre-2012) initiated 5 Jan 2005 on shared 510(k) K982279
    • Terminated Z-0532-05 FDA Unclassified (pre-2012) initiated 5 Jan 2005 on shared 510(k) K982279

    An issue with the pace detect function was discovered on a 9200 II monitor. Could result in a falsely high or low heart rate reading.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MHX
Models / Variants
Advisor Model # Bci 9200
Device Class
Class II
Regulation
21 CFR Part 870.1025
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Vital Signs Monitor; Advisor Model # BCI 9200 is a Physiological Patient Monitor (with Arrhythmia Detection or Alarms) designed to continuously assess multiple vital signs. It provides real-time monitoring of electrocardiogram (ECG), respiration, non-invasive blood pressure, pulse oximetry, invasive pressures, and temperature, enabling comprehensive patient assessment in clinical settings.

This device is intended for use in hospital or clinical environments, offering a portable, tabletop design for multi-parameter monitoring. Supplied as a reusable medical device, it requires appropriate sterilization and maintenance protocols. The BCI 9200 has received FDA 510K clearance under the Cardiovascular Advisory Committee and is classified as a Class II device under regulation number 870.1025. It is not intended for MRI use and must be stored in accordance with manufacturer guidelines.

Other devices from Bci Intl., Inc.

See all devices from Bci Intl., Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Vital Signs Monitor Advisor Model # BCI 9200 used for?

    The Vital Signs Monitor Advisor Model # BCI 9200 is designed for continuous assessment of multiple vital signs including electrocardiogram (ECG), respiration, non-invasive blood pressure, pulse oximetry, invasive pressures, and temperature, providing comprehensive patient monitoring in hospital or clinical environments.

  • How is the BCI 9200 supplied and is it reusable?

    The BCI 9200 is supplied as a reusable medical device with a portable, tabletop design. It requires appropriate sterilization and maintenance protocols according to manufacturer guidelines for continued safe and effective use in clinical settings.

  • What regulatory status does the BCI 9200 have?

    The BCI 9200 has received FDA 510K clearance under the Cardiovascular Advisory Committee and is classified as a Class II device under regulation number 870.1025. It is not intended for MRI use and must be stored according to manufacturer guidelines.

  • What parameters does the BCI 9200 monitor?

    The BCI 9200 provides real-time monitoring of electrocardiogram (ECG), respiration, non-invasive blood pressure, pulse oximetry, invasive pressures, and temperature, enabling comprehensive patient assessment in clinical settings with arrhythmia detection capabilities.